Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease-Reference-Cited by-同舟云学术

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

Published:2020-10-08 Issue:4 Volume:116 Page:723-732
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Pons Monica,Augustin Salvador,Scheiner Bernhard,Guillaume Maeva,Rosselli Matteo,Rodrigues Susana G.,Stefanescu Horia,Ma Mang M.,Mandorfer Mattias,Mergeay-Fabre Mayka,Procopet Bogdan,Schwabl Philipp,Ferlitsch Arnulf,Semmler Georg,Berzigotti Annalisa,Tsochatzis Emmanuel,Bureau Christophe,Reiberger Thomas,Bosch Jaime,Abraldes Juan G.,Genescà Joan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension;de Franchis;J Hepatol,2015

2. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis;Lemoine;Aliment Pharmacol Ther,2008

3. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease;Bureau;Aliment Pharmacol Ther,2008

4. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis;Berzigotti;Gastroenterology,2013

5. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study;Abraldes;Hepatology,2016

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refractory massive chylothorax following robot-assisted laparoscopic splenectomy with pericardial devascularization treated with trans-jugular intrahepatic portosystemic shunt: a case report;Frontiers in Medicine;2024-09-04

2. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-09

3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

4. Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications;Cancers;2024-08-19

5. Editorial: Tracking the course of Wilson's disease: Authors' reply;Alimentary Pharmacology & Therapeutics;2024-08-09